APO RESEARCH · REPORT
Fibrinogen
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Product & engineering
Understand the product.
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Selected research
Industry Research
Fibrinogen Industry Research Report 2026
Market perspective
Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.
Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.
Report Scope
Read the full market overview
This report quantifies the global Fibrinogen market in terms of revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fibrinogen Market by Company
CSL Behring
LFB Group
Shanghai RAAS Blood Products
Jiangxi Boya Bio-Pharmaceutical
Hualan Biological Engineering
Harbin Pacific Biopharmaceutical
GREEN CROSS
Shanghai XinXing Medical
Taibang Biologic
Octapharma
Fibrinogen Segment by Type
Human Fibrinogen
Animal Fibrinogen
Fibrinogen Segment by Application
Congenital Fibrinogen Deficiency
Surgical Procedures
Others
Fibrinogen Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fibrinogen market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fibrinogen and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fibrinogen.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fibrinogen manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fibrinogen by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fibrinogen in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Fibrinogen
- Animal Fibrinogen
Applications
- Congenital Fibrinogen Deficiency
- Surgical Procedures
- Others
Companies covered
- CSL Behring
- LFB Group
- Shanghai RAAS Blood Products
- Jiangxi Boya Bio-Pharmaceutical
- Hualan Biological Engineering
- Harbin Pacific Biopharmaceutical
- GREEN CROSS
- Shanghai XinXing Medical
- Taibang Biologic
- Octapharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fibrinogen Market Size (2021-2032)
- 2.2.2 Global Fibrinogen Sales (2021-2032)
- 2.2.3 Global Fibrinogen Market Average Price (2021-2032)
- 2.3 Fibrinogen by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Human Fibrinogen
- 2.3.3 Animal Fibrinogen
- 2.4 Fibrinogen by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Congenital Fibrinogen Deficiency
- 2.4.3 Surgical Procedures
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fibrinogen Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fibrinogen Sales (Kg) of Manufacturers (2021-2026)
- 3.3 Global Fibrinogen Revenue of Manufacturers (2021-2026)
- 3.4 Global Fibrinogen Average Price by Manufacturers (2021-2026)
- 3.5 Global Fibrinogen Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fibrinogen, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fibrinogen, Product Type & Application
- 3.8 Global Manufacturers of Fibrinogen, Established Date
- 3.9 Global Fibrinogen Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 CSL Behring
- 4.1.1 CSL Behring Company Information
- 4.1.2 CSL Behring Business Overview
- 4.1.3 CSL Behring Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 CSL Behring Fibrinogen Product Portfolio
- 4.1.5 CSL Behring Recent Developments
- 4.2 LFB Group
- 4.2.1 LFB Group Company Information
- 4.2.2 LFB Group Business Overview
- 4.2.3 LFB Group Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 LFB Group Fibrinogen Product Portfolio
- 4.2.5 LFB Group Recent Developments
- 4.3 Shanghai RAAS Blood Products
- 4.3.1 Shanghai RAAS Blood Products Company Information
- 4.3.2 Shanghai RAAS Blood Products Business Overview
- 4.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai RAAS Blood Products Fibrinogen Product Portfolio
- 4.3.5 Shanghai RAAS Blood Products Recent Developments
- 4.4 Jiangxi Boya Bio-Pharmaceutical
- 4.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information
- 4.4.2 Jiangxi Boya Bio-Pharmaceutical Business Overview
- 4.4.3 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Jiangxi Boya Bio-Pharmaceutical Fibrinogen Product Portfolio
- 4.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Developments
- 4.5 Hualan Biological Engineering
- 4.5.1 Hualan Biological Engineering Company Information
- 4.5.2 Hualan Biological Engineering Business Overview
- 4.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hualan Biological Engineering Fibrinogen Product Portfolio
- 4.5.5 Hualan Biological Engineering Recent Developments
- 4.6 Harbin Pacific Biopharmaceutical
- 4.6.1 Harbin Pacific Biopharmaceutical Company Information
- 4.6.2 Harbin Pacific Biopharmaceutical Business Overview
- 4.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Product Portfolio
- 4.6.5 Harbin Pacific Biopharmaceutical Recent Developments
- 4.7 GREEN CROSS
- 4.7.1 GREEN CROSS Company Information
- 4.7.2 GREEN CROSS Business Overview
- 4.7.3 GREEN CROSS Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GREEN CROSS Fibrinogen Product Portfolio
- 4.7.5 GREEN CROSS Recent Developments
- 4.8 Shanghai XinXing Medical
- 4.8.1 Shanghai XinXing Medical Company Information
- 4.8.2 Shanghai XinXing Medical Business Overview
- 4.8.3 Shanghai XinXing Medical Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Shanghai XinXing Medical Fibrinogen Product Portfolio
- 4.8.5 Shanghai XinXing Medical Recent Developments
- 4.9 Taibang Biologic
- 4.9.1 Taibang Biologic Company Information
- 4.9.2 Taibang Biologic Business Overview
- 4.9.3 Taibang Biologic Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Taibang Biologic Fibrinogen Product Portfolio
- 4.9.5 Taibang Biologic Recent Developments
- 4.10 Octapharma
- 4.10.1 Octapharma Company Information
- 4.10.2 Octapharma Business Overview
- 4.10.3 Octapharma Fibrinogen Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Octapharma Fibrinogen Product Portfolio
- 4.10.5 Octapharma Recent Developments
5 Global Fibrinogen Market Scenario by Region
- 5.1 Global Fibrinogen Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fibrinogen Sales by Region: 2021-2032
- 5.2.1 Global Fibrinogen Sales by Region: 2021-2026
- 5.2.2 Global Fibrinogen Sales by Region: 2027-2032
- 5.3 Global Fibrinogen Revenue by Region: 2021-2032
- 5.3.1 Global Fibrinogen Revenue by Region: 2021-2026
- 5.3.2 Global Fibrinogen Revenue by Region: 2027-2032
- 5.4 North America Fibrinogen Market Facts & Figures by Country
- 5.4.1 North America Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fibrinogen Sales by Country (2021-2032)
- 5.4.3 North America Fibrinogen Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fibrinogen Market Facts & Figures by Country
- 5.5.1 Europe Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fibrinogen Sales by Country (2021-2032)
- 5.5.3 Europe Fibrinogen Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fibrinogen Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fibrinogen Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fibrinogen Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fibrinogen Market Facts & Figures by Country
- 5.7.1 South America Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fibrinogen Sales by Country (2021-2032)
- 5.7.3 South America Fibrinogen Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Fibrinogen Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fibrinogen Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fibrinogen Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fibrinogen Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fibrinogen Sales by Type (2021-2032)
- 6.1.1 Global Fibrinogen Sales by Type (2021-2032) & (Kg)
- 6.1.2 Global Fibrinogen Sales Market Share by Type (2021-2032)
- 6.2 Global Fibrinogen Revenue by Type (2021-2032)
- 6.2.1 Global Fibrinogen Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fibrinogen Revenue Market Share by Type (2021-2032)
- 6.3 Global Fibrinogen Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fibrinogen Sales by Application (2021-2032)
- 7.1.1 Global Fibrinogen Sales by Application (2021-2032) & (Kg)
- 7.1.2 Global Fibrinogen Sales Market Share by Application (2021-2032)
- 7.2 Global Fibrinogen Revenue by Application (2021-2032)
- 7.2.1 Global Fibrinogen Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fibrinogen Revenue Market Share by Application (2021-2032)
- 7.3 Global Fibrinogen Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fibrinogen Value Chain Analysis
- 8.1.1 Fibrinogen Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fibrinogen Production Mode & Process
- 8.2 Fibrinogen Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fibrinogen Distributors
- 8.2.3 Fibrinogen Customers
9 Global Fibrinogen Analyzing Market Dynamics
- 9.1 Fibrinogen Industry Trends
- 9.2 Fibrinogen Industry Drivers
- 9.3 Fibrinogen Industry Opportunities and Challenges
- 9.4 Fibrinogen Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst